Evidence map›Paper›PMID 35271658›Full record

ArticlePloS one2022

Facilitators and barriers for clinical implementation of a 30-minute point-of-care test for Neisseria gonorrhoeae and Chlamydia trachomatis into clinical care: A qualitative study within sexual health services in England.

Agata Pacho, Emma M Harding-Esch, Emma G Heming De-Allie, Laura Phillips, Martina Furegato, S Tariq Sadiq, Sebastian S Fuller

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Agata PachoInstitute for Infection and Immunity, Applied Diagnostic Research and Evaluation Unit, St George's University of London, London, United Kingdom.
Emma M Harding-EschInstitute for Infection and Immunity, Applied Diagnostic Research and Evaluation Unit, St George's University of London, London, United Kingdom.ORCID 0000-0002-1432-8109
Emma G Heming De-AllieInstitute for Infection and Immunity, Applied Diagnostic Research and Evaluation Unit, St George's University of London, London, United Kingdom.
Laura PhillipsInstitute for Infection and Immunity, Applied Diagnostic Research and Evaluation Unit, St George's University of London, London, United Kingdom.
Martina FuregatoInstitute for Infection and Immunity, Applied Diagnostic Research and Evaluation Unit, St George's University of London, London, United Kingdom.
S Tariq SadiqInstitute for Infection and Immunity, Applied Diagnostic Research and Evaluation Unit, St George's University of London, London, United Kingdom.
Sebastian S FullerInstitute for Infection and Immunity, Applied Diagnostic Research and Evaluation Unit, St George's University of London, London, United Kingdom.
St George's, University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Point-of-care tests (POCTs) to diagnose sexually transmitted infections (STIs) have potential to positively impact patient management and patient perceptions of clinical services. Yet there remains a disconnect between development of new technologies and their implementation into clinical care. With the advent of new STI POCTs arriving to the global market, guidance for their successful adoption and implementation into clinical services is urgently needed. We conducted qualitative in-depth interviews with professionals prior to and post-implementation of a Chlamydia trachomatis/Neisseria gonorrhoeae POCT into clinical services in England to define key stakeholder roles and explore the process of POCT integration. Participants self-identified themselves as key stakeholders in the STI POCT adoption and/or implementation processes. Data consisted of interview transcripts, which were analysed thematically using NVIVO 11. Six sexual health services were included in the study; three of which have implemented POCTs. We conducted 40 total interviews: 31 prior to POCT implementation and 9 follow-up post-implementation. Post-implementation data showed that implementation plans required little or no change during service evaluation. Lead clinicians and managers self-identified as key stakeholders for the decision to purchase, while nurses self-identified as "change champions" for implementation. Many identified senior clinical staff as those most likely to introduce and drive change. However, participants stressed the importance of engaging all clinical staff in implementation. While the accuracy of the POCT, its positive impact on patient management and the ease of its integration within existing pathways were considered essential, costs of purchasing and utilising the technology were identified as central to the decision to purchase. Our study shows that key decision-makers for adoption and implementation require STI POCTs to have laboratory-comparable accuracy and be affordable for purchase and ongoing use. Further, successful integration of POCTs into sexual health services relies on supportive interpersonal relationships between all levels of staff.

Indexed as

Chlamydia InfectionsGonorrheaPoint-of-Care TestingSexually Transmitted DiseasesChlamydia trachomatisEnglandHealth ServicesHumansNeisseria gonorrhoeaeQualitative Research

Identifiers

PMID35271658
PMCPMC8912210
OpenAlexW4220920149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.